The Cell and Gene Therapy Services market refers to the industry that provides services for the development, manufacturing, and delivery of cell and gene therapies. As the Cell and Gene Therapy Services market size continues to grow, it is essential to understand the growth outlook, market forecast, and industry expansion. The scope of this market encompasses a range of services, including cell banking, vector manufacturing, and analytical testing. With a current market size of approximately $14.8 billion, the Cell and Gene Therapy Services market is expected to experience significant growth, driven by advancements in gene editing technologies and increasing demand for personalized medicines. The market is forecasted to grow at a CAGR of 14.5% from 2026 to 2033, driven by macro drivers such as regulatory support, technological advancements, and rising consumer awareness.